The International Waldenstrom’s Macroglobulinemia Forum (IWMF) recently held their annual educational forum. Jorge Castillo, MD, Clinical Director of the Bing Center for Waldenstrom Macroglobulinemia, reports on some of the important updates from the forum. Dr. Castillo discusses how bone marrow biopsies should be evaluated and the importance of genetic profiling testing. He also explains the use of BTK inhibitors and the status of certain clinical trials, including those investigating new Bcl-2 inhibitors.

Click the link below to read the transcript and/or view the video: